Clinical Trials Logo

Clopidogrel Resistance clinical trials

View clinical trials related to Clopidogrel Resistance.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02008123 Withdrawn - Clinical trials for Secondary Stroke Prevention

Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant

Start date: August 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether adding primidone will improve the metabolism of clopidogrel thereby increasing metabolite levels within the blood stream and platelet response to clopidogrel in patients who were previously found to lack adequate response to clopidogrel. This information could help overcome clopidogrel resistance in patients who are at risk for stroke or transient ischemic attack (TIA).